Wealth Quarterback LLC Astrazeneca PLC Transaction History

Wealth Quarterback LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$59.26 - $71.14 $10,489 - $12,591	-177 Closed	0 $0
Q3 2021 Nov 17, 2021	BUY	$55.56 - $60.79 $55 - $60	1 Added 0.57%	177 $11,000
Q2 2021 Aug 11, 2021	BUY	$48.42 - $60.18 $8,521 - $10,591	176 New	176 $11,000
Q1 2020 May 14, 2020	SELL	$37.79 - $51.33 $85,292 - $115,851	-2,257 Closed	0 $0
Q4 2019 Feb 27, 2020	SELL	$42.46 - $50.46 $1.97 Billion - $2.34 Billion	-46,350,851 Reduced 100.0%	2,257 $112,000
Q4 2019 Feb 18, 2020	BUY	$42.46 - $50.46 $1.97 Billion - $2.34 Billion	46,353,108 New	46,353,108 $2.31 Billion

1,359

475M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $203B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Wealth Quarterback LLC, based on Form 13F filings with the SEC.

Stay updated on Wealth Quarterback LLC with notifications on news.